RxDoctor Payments Data

John Tibble, DO

Family Medicine · Chicago Heights, ILNPI 1376960542

Payments from drug & device makers

$406in general payments, 2019–2025

Across 25 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$102
  • AstraZeneca$70
  • Novo Nordisk$57
  • Merck$41
  • Novartis$32
  • Gilead$29
  • plus $76 from 4 others

What the payments were for

  • Food & beverage$406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$406 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$113,891
Medicare patients
346
Services billed
1,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin92$130,985
OzempicSemaglutide64$98,953
EliquisApixaban71$87,943
MounjaroTirzepatide55$85,952
FarxigaDapagliflozin Propanediol46$55,651
TrulicityDulaglutide35$51,599
RybelsusSemaglutide26$47,761
JanuviaSitagliptin Phosphate29$40,476
XareltoRivaroxaban29$35,327
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$34,887
TradjentaLinagliptin20$29,122
Breo ElliptaFluticasone/Vilanterol38$21,412
Tresiba Flextouch U-200Insulin Degludec16$17,727
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$7,528
BrilintaTicagrelor12$7,047

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$57$146,71590 claims
Lilly USA, LLCMounjaro, Trulicity$19$137,55290 claims
PfizerEliquis, Dilantin$102$91,24383 claims
AstraZenecaFarxiga, Brilinta$70$62,69858 claims
MerckJanuvia$41$40,47629 claims
Johnson & JohnsonXarelto$22$35,32729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Chicago Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →